论文部分内容阅读
北京市药品不良反应监测中心公布的“2005年全市药品医疗器械监测结果通报”显示:2005年北京市药品不良反应报表中,涉及重度药品不良反应前5名的药物中头孢菌素类抗菌药占3个,其中头孢哌酮钠舒巴坦钠所致严重不良反应位居前列。这一方面可能因其临床应用广泛,增加了它发生不良反应的几率,另一方面,其本身存在可引起不良反应的特点也不容忽视。就此,记者采访了北京市药品不良反应监测中心特聘专家。
Beijing Institute of Drug Adverse Reaction Monitoring Center announced in 2005 “the city’s medical equipment monitoring results notification” shows: 2005 Beijing adverse drug reaction reports, involving the top five adverse drug reactions in the drug cephalosporins antibacterial accounted for 3, of which cefoperazone sodium and sulbactam sodium caused serious adverse reactions among the forefront. This may be due to its wide range of clinical applications, increasing its chances of adverse reactions, on the other hand, its own existence can cause adverse reactions can not be ignored. In this connection, the reporter interviewed the Beijing Municipal Institute of Drug Adverse Drug Reaction Monitoring Center Distinguished experts.